Decision: UK Anti-Doping v Robbie Turley
A Decision in the case of the UK Anti-Doping (UKAD) v Robbie Turley has been published by the National Anti-Doping Panel (NADP).
On 07 April 2017, professional boxer Robbie Turley was subject to In-Competition test following a contest for the Commonwealth Super Bantamweight Title. Analysis of Mr Turley’s urine sample returned an Adverse Analytical Finding for Furosemide. Mr Turley was subsequently charged with an Anti-Doping Rule Violation (ADRV) for the Presence of a Prohibited Substance under Anti-Doping Rule (ADR) Article 2.1.
As UKAD did not seek to establish that the violation was intentional, the starting point for the applicable period of Ineligibility was 2 years. After assessing Mr Turley’s level of fault, the NADP Tribunal consisting of Robert Englehart QC (Chairman) and Blondel Thompson determined the applicable period of Ineligibility to be imposed should be 12 months.
Mr Turley’s ban will run from 07 April 2017, the date of sample collection, until midnight on 06 April 2018.
The full NADP Decision can be accessed via the related links tab on the right-hand side.
The National Anti-Doping Panel (NADP) is the United Kingdom’s independent tribunal responsible for adjudicating anti-doping disputes in sport. It is operated by Sport Resolutions and is entirely independent of UK Anti-Doping and the RFU, who are responsible for investigating, charging and prosecuting cases before the NADP.